Amphastar Pharmaceuticals AMPH Prepaid & Other Current
Prepaid & Other Current at other companies
Other financials
Where this comes from
Reported directly by Amphastar Pharmaceuticals in its filing.
Tagged under the XBRL concept us-gaap:PrepaidExpenseAndOtherAssetsCurrent.
The official record: Amphastar Pharmaceuticals’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →
Ask your AI about Amphastar Pharmaceuticals's prepaid & other current.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Amphastar Pharmaceuticals's prepaid & other current?
- Amphastar Pharmaceuticals (AMPH) reported prepaid & other current of $11.65M in Q1 2026.
- How has Amphastar Pharmaceuticals's prepaid & other current changed year-over-year?
- Amphastar Pharmaceuticals's prepaid & other current decreased by 34.5% year-over-year, from $17.77M to $11.65M.
- What is the long-term trend for Amphastar Pharmaceuticals's prepaid & other current?
- Over 5 years (2020 to 2025), Amphastar Pharmaceuticals's prepaid & other current has grown at a 14.2% compound annual growth rate (CAGR), from $6.78M to $13.15M.
- What does prepaid & other current mean?
- Advance payments for expenses (rent, insurance, subscriptions) plus miscellaneous current assets not classified elsewhere.